High density lipoprotein cholesterol and apolipoprotein A-I levels in 32–33-year-old women on steroid contraceptives—differences between two frequently used low-estrogen pills
| Autor: | C.M. Van Gent, L. W. Hessel, Louis M. Havekes, A.C. Arntzenius, C.I. Stegerhoek |
|---|---|
| Rok vydání: | 1981 |
| Předmět: |
Adult
Medroxyprogesterone medicine.medical_specialty Alcohol Drinking Apolipoprotein B Clinical Biochemistry Medroxyprogesterone Acetate Ethinyl Estradiol Biochemistry Lynestrenol chemistry.chemical_compound High-density lipoprotein Internal medicine Norgestrel medicine Humans Medroxyprogesterone acetate Levonorgestrel Apolipoprotein A-I biology business.industry Cholesterol Cholesterol HDL Smoking Biochemistry (medical) Mestranol General Medicine Apolipoproteins Endocrinology chemistry Delayed-Action Preparations biology.protein Female lipids (amino acids peptides and proteins) Norethindrone Lipoproteins HDL business Contraceptives Oral medicine.drug |
| Zdroj: | Clinica Chimica Acta. 116:223-229 |
| ISSN: | 0009-8981 |
| DOI: | 10.1016/0009-8981(81)90026-7 |
| Popis: | High density lipoprotein cholesterol and apolipoprotein A-I levels were measured in about one thousand 32–33-year-old women taking part in a cardiovascular screening programme. After corrections for differences in smoking habits and use of alcoholic drinks women on various types of steroid contraceptives had widely different levels of high density lipoprotein cholesterol and apolipoprotein A-I. Lowest levels were found in users of lynestrenol-containing minipills (progestagen-only pills) and highest levels in lynestrenol-containing low-estrogen pills. Of the two commonly used low-estrogen pills (“sub-50 pills”) one type (containing levonorgestrel) was associated with elevated and the other (containing lynestrenol) with depressed levels of high density lipoprotein cholesterol and apolipoprotein A-I as compared with the reference group of non-users of oral contraceptives. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|